Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Technology
  • Industry: Semiconductors
  • Sub-Industry: Semiconductor Mfg

TG2:GR

0.618 EUR 0.051 7.62%

As of 15:41:27 ET on 04/30/2015.

Snapshot for CollabRx Inc (TG2)

Open: 0.669 Day's Range: 0.618 - 0.702 Volume: 0
Previous Close: 0.669 52wk Range: 0.406 - 2.280 1-Yr Rtn: -71.95%

Stock Chart for TG2

No chart data available.
  • TG2:GR 0.680
  • 1D
  • 1M
  • 1Y
0.669
Interactive TG2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TG2

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 6.15
Shares Outstanding (M) 9.95
30 Day Average Volume 882
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/09/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TG2

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TG2

CollabRx uses information technology to inform personalized cancer treatment planning by combining the world's knowledge on cutting-edge therapies with specific insights from the nation's top cancer experts starting with the area of greatest need advanced cancers in patients who have effectively exhausted the standard of care.

Thomas R Mika "Tom"Chairman/Pres/CEO/Acting CFOSmruti J VidwansChief Science Officer
Clifford BaronVP/COO
More Company Profile & Key Executives for TG2

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil